medRxivGenetic & Genomic MedicinePreprint
Combining Transdiagnostic and Disorder-Level GWAS Enhances Precision of Psychiatric Genetic Risk Profiles in a Multi-Ancestry Sample
Yousef KhaniD, Christal N. DavisiD, Zeal JinwalaiD, Kyra L. FeueriD, Sylvanus ToikumoiD, Emily E. HartwelliD, Sandra Sanchez‐RoigeiD, Roseann Elizabeth PetersoniD, Alexander Samir HatoumiD, Henry R. KranzleriD, Rachel L. KemberiD
Abstract
The etiology of substance use disorders (SUDs) and psychiatric disorders reflects a combination of both transdiagnostic (i.e., common) and disorder-level (i.e., independent) genetic risk factors. We applied genomic structural equation modeling to examine these genetic factors across SUDs, psychotic, mood, and anxiety disorders using genome-wide association studies (GWAS) of European-(EUR) and African-ancestry (AFR) individuals. In EUR individuals, transdiagnostic genetic factors represented SUDs (143 lead single nucleotide polymorphisms [SNPs]), psychotic (162 lead SNPs), and mood/anxiety disorders (112 lead SNPs). We identified two novel SNPs for mood/anxiety disorders that have probable regulatory roles on FOXP1, NECTIN3, and BTLA genes. In AFR individuals, genetic factors represented SUDs (1 lead SNP) and psychiatric disorders (no significant SNPs). The SUD factor lead SNP, although previously significant in EUR- and cross-ancestry GWAS, is a novel finding in AFR individuals. Shared genetic variance accounted for overlap between SUDs and their psychiatric comorbidities, with second-order GWAS identifying up to 12 SNPs not significantly associated with either first-order factor in EUR individuals. Finally, common and independent genetic effects showed different associations with psychiatric, sociodemographic, and medical phenotypes. For example, the independent components of schizophrenia and bipolar disorder had distinct associations with affective and risk-taking behaviors, and phenome-wide association studies identified medical conditions associated with tobacco use disorder independent of the broader SUDs factor. Thus, combining transdiagnostic and disorder-level genetic approaches can improve our understanding of co-occurring conditions and increase the specificity of genetic discovery, which is critical for psychiatric disorders that demonstrate considerable symptom and etiological overlap.
- organism: human
- assay: GWAS summary statistics
- research focus: GWAS / association mapping
- research focus: fine-mapping
- research focus: benchmarking
- approach: statistical model
- Citations
- 6
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pleiotropic genetic architecture linking schizophrenia and substance use disorders
Selena Aranda, Dóra Koller, … Bru Cormand·medRxiv·Sep 4, 2026
- Application of polygenic scores to a deeply phenotyped sample enriched for substance use disorders reveals extensive pleiotropy with psychiatric and medical traits
Emily E. Hartwell, Zeal Jinwala, … Rachel L. Kember·NeuropsychopharmacologyPeer-reviewed·Jul 23, 2024
- Genomic relationships across psychiatric disorders including substance use disorders
Abdel Abdellaoui, Dirk J. A. Smit, … Karin J. H. Verweij·Drug and Alcohol DependencePeer-reviewed·Jan 19, 2021
- Elucidating the Joint Genetic Architecture of Mood Disorder and Schizophrenia
Max Lam, Meiling Thompson, … Hailiang Huang·medRxiv·Sep 14, 2020
- Substance use disorders exhibit unique and disorder specific genetic associations with externalizing and internalizing psychopathology
Holly E. Poore, Maia Choi, … Danielle M. Dick·medRxiv·Jan 22, 2026
- The Landscape of Shared and Divergent Genetic Influences across 14 Psychiatric Disorders
Andrew David Grotzinger, Josefin Werme, … Jordan W. Smoller·medRxiv·Jan 14, 2025